News in brief: Trikafta PBS listing still up in the air; New CRE guidance on COVID-19 in severe asthma; Little evidence to support GORD treatment in asthma

Trikafta PBS listing still up in the air Advocacy groups for cystic fibrosis patients say they are lobbying behind the scenes to have Trikafta (elexacaftor/tezacaftor/ivacaftor) listed on the PBS after the Pharmaceutical Benefits Advisory Committee deferred a decision on a positive recommendation at its March meeting. Nettie Burke, CEO of Cystic Fibrosis Australia said the ...

Already a member?

Login to keep reading.

© 2021 the limbic